| scholarly article | Q13442814 |
| P50 | author | Sudhanshu P Raikwar | Q59694413 |
| P2093 | author name string | Duraisamy Kempuraj | |
| Shankar S Iyer | |||
| Asgar Zaheer | |||
| Ramasamy Thangavel | |||
| Smita Zaheer | |||
| Govindhasamy Pushpavathi Selvakumar | |||
| Mohammad E Ahmed | |||
| Shireen Mentor | |||
| Iuliia Dubova | |||
| P2860 | cites work | Mast Cell Proteases Activate Astrocytes and Glia-Neurons and Release Interleukin-33 by Activating p38 and ERK1/2 MAPKs and NF-κB | Q89146453 |
| Blood-brain barrier regulation in psychiatric disorders | Q89390782 | ||
| New approaches for the treatment of Alzheimer's disease | Q90012827 | ||
| Depressive- and anxiety-like phenotypes in young adult APPSwe/PS1dE9 transgenic mice with insensitivity to chronic mild stress | Q90251029 | ||
| Neuroimmune and Inflammatory Signals in Complex Disorders of the Central Nervous System | Q90282854 | ||
| Association of childhood stress with late-life dementia and Alzheimer's disease: the KIHD study | Q90312656 | ||
| Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines | Q90358268 | ||
| Targeting mast cell as a neuroprotective strategy | Q90565468 | ||
| Stress, inflammation and natural treatments | Q90687397 | ||
| Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects | Q90687409 | ||
| Chronic pain in refugees with posttraumatic stress disorder (PTSD): A systematic review on patients' characteristics and specific interventions | Q90760359 | ||
| Acute stress and subsequent health outcomes: A systematic review | Q90876851 | ||
| Roles of inflammation, neurogenic inflammation, and neuroinflammation in pain | Q93196709 | ||
| Tauopathy and neurodegeneration: A role for stress | Q93203071 | ||
| Tetramethoxyluteolin for the Treatment of Neurodegenerative Diseases | Q93205949 | ||
| New concepts in neuroinflammation: mast cells pro-inflammatory and anti-inflammatory cytokine mediators | Q95585945 | ||
| Nerve growth factor: a neuroimmune crosstalk mediator for all seasons | Q39098815 | ||
| Hypoxic Stress and Inflammatory Pain Disrupt Blood-Brain Barrier Tight Junctions: Implications for Drug Delivery to the Central Nervous System | Q39206409 | ||
| Mast cells in neuroinflammation and brain disorders. | Q39302923 | ||
| Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor | Q40412140 | ||
| Opening of the blood-brain barrier preceding cortical edema in a severe attack of FHM type II. | Q40505035 | ||
| Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration | Q41097407 | ||
| Abnormalities in hippocampal functioning with persistent pain. | Q42182780 | ||
| TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway | Q42320459 | ||
| Chronic pain and adult hippocampal neurogenesis: translational implications from preclinical studies | Q42364438 | ||
| Non-invasive assessment of blood-brain barrier (BBB) permeability using a gamma camera to detect 99technetium-gluceptate extravasation in rat brain | Q42511811 | ||
| Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress | Q44220866 | ||
| Corticotropin-releasing factor (CRF) can directly affect brain microvessel endothelial cells | Q44380897 | ||
| Stress-induced dura vascular permeability does not develop in mast cell-deficient and neurokinin-1 receptor knockout mice | Q44516016 | ||
| Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells | Q44630410 | ||
| Regulation of IL-18 expression by CRH in mouse microglial cells | Q46462595 | ||
| Visceral Inflammation and Immune Activation Stress the Brain | Q47137050 | ||
| Mast Cell Activation in Brain Injury, Stress, and Post-traumatic Stress Disorder and Alzheimer's Disease Pathogenesis | Q47148054 | ||
| Microglia express ABI3 in the brains of Alzheimer's disease and Nasu-Hakola disease | Q47154155 | ||
| Neuroinflammatory responses in Alzheimer's disease | Q47259208 | ||
| Social stress induces neurovascular pathology promoting depression | Q47282467 | ||
| Neuroprotective effect of formononetin in ameliorating learning and memory impairment in mouse model of Alzheimer's disease | Q47345987 | ||
| Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain | Q47368165 | ||
| Corticotropin-Releasing Hormone Suppresses Synapse Formation in the Hippocampus of Male Rats via Inhibition of CXCL5 Secretion by Glia | Q47617331 | ||
| Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain. | Q47687675 | ||
| Cross-Talk between Glia, Neurons and Mast Cells in Neuroinflammation Associated with Parkinson's Disease. | Q47738283 | ||
| Neuroinflammation, Mast Cells, and Glia: Dangerous Liaisons | Q47893052 | ||
| Acute stress shortens the time to onset of experimental allergic encephalomyelitis in SJL/J mice | Q48294983 | ||
| Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex. | Q48484079 | ||
| Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. | Q48871284 | ||
| Neuroinflammation in Alzheimer's Disease: Pleiotropic Roles for Cytokines and Neuronal Pentraxins | Q49808096 | ||
| Mast cell-neural interactions contribute to pain and itch | Q50068940 | ||
| NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice | Q24604235 | ||
| Pain in Neurodegenerative Disease: Current Knowledge and Future Perspectives | Q26745618 | ||
| Microglia and mast cells: two tracks on the road to neuroinflammation | Q26865144 | ||
| The Role of Mast Cells in Alzheimer's Disease | Q28072118 | ||
| Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells | Q31808140 | ||
| Cholinergic Nociceptive Mechanisms in Rat Meninges and Trigeminal Ganglia: Potential Implications for Migraine Pain | Q33607006 | ||
| Adverse stress, hippocampal networks, and Alzheimer's disease | Q33708011 | ||
| Decreased hippocampal volume in healthy girls at risk of depression | Q33752419 | ||
| Effects of stress and stress hormones on amyloid-beta protein and plaque deposition | Q34001966 | ||
| Sex- and brain region-specific acceleration of β-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease. | Q34332342 | ||
| Overactivation of corticotropin-releasing factor receptor type 1 and aquaporin-4 by hypoxia induces cerebral edema | Q34583444 | ||
| Augmented expression of glia maturation factor in Alzheimer's disease | Q35242871 | ||
| Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial | Q35579238 | ||
| Disruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder? | Q35649716 | ||
| Mast cell degranulation distinctly activates trigemino-cervical and lumbosacral pain pathways and elicits widespread tactile pain hypersensitivity | Q35690567 | ||
| Epigenetic modification of hippocampal Bdnf DNA in adult rats in an animal model of post-traumatic stress disorder. | Q35910727 | ||
| Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy? | Q36013705 | ||
| Mast Cell-Mediated Mechanisms of Nociception | Q36404141 | ||
| Restraint Stress-Induced Morphological Changes at the Blood-Brain Barrier in Adult Rats | Q36460596 | ||
| Corticotropin-releasing hormone and the blood-brain-barrier | Q36664658 | ||
| Junctional proteins of the blood-brain barrier: New insights into function and dysfunction | Q36812374 | ||
| Glia maturation factor modulates beta-amyloid-induced glial activation, inflammatory cytokine/chemokine production and neuronal damage | Q36983964 | ||
| Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia | Q36991785 | ||
| Oxidative stress and β-amyloid protein in Alzheimer's disease | Q37928994 | ||
| Tryptase, a mediator of human mast cells | Q37980688 | ||
| Effect of stress on brain inflammation and multiple sclerosis | Q38093888 | ||
| S100B as a marker for brain damage and blood-brain barrier disruption following exercise | Q38160208 | ||
| Corticotropin-releasing hormone, microglia and mental disorders. | Q38227359 | ||
| Experimental pain processing in individuals with cognitive impairment: current state of the science | Q38548382 | ||
| The blood-brain barrier endothelium: a target for pro-inflammatory cytokines | Q38628917 | ||
| Therapeutic approach to pain in neurodegenerative diseases: current evidence and perspectives. | Q38892540 | ||
| Mast Cell - Glia Dialogue in Chronic Pain and Neuropathic Pain: Blood-Brain Barrier Implications | Q38940563 | ||
| Bidirectional relationship of mast cells-neurovascular unit communication in neuroinflammation and its involvement in POCD. | Q39084392 | ||
| Inhibition of TNF-α protects in vitro brain barrier from ischaemic damage. | Q50915151 | ||
| Mindfulness Meditation for Primary Headache Pain: A Meta-Analysis. | Q51734847 | ||
| An Inflammation-Centric View of Neurological Disease: Beyond the Neuron. | Q52331711 | ||
| Targeted Gene Editing of Glia Maturation Factor in Microglia: a Novel Alzheimer's Disease Therapeutic Target. | Q52431925 | ||
| Thymoquinone protects against cerebral small vessel disease: Role of antioxidant and anti-inflammatory activities. | Q52569259 | ||
| Neurogenic inflammation and its role in migraine. | Q53835617 | ||
| Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. | Q54319446 | ||
| Interactions between stress and physical activity on Alzheimer's disease pathology. | Q55083969 | ||
| The relationship between stress and Alzheimer's disease. | Q55177547 | ||
| Effects of chronic noise exposure on the microbiome-gut-brain axis in senescence-accelerated prone mice: implications for Alzheimer's disease. | Q55442741 | ||
| Chronic stress as a risk factor for Alzheimer's disease: Roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress. | Q55505826 | ||
| Opening of the blood-brain barrier preceding cortical edema in a severe attack of FHM type II | Q56971320 | ||
| Mast Cells in Neuroimmune Interactions | Q57187860 | ||
| Stress-induced modulation of pain: Role of the endogenous opioid system | Q57498470 | ||
| Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke | Q58086102 | ||
| Glia Maturation Factor and Mast Cell-Dependent Expression of Inflammatory Mediators and Proteinase Activated Receptor-2 in Neuroinflammation | Q58114607 | ||
| Chronic Pain and Chronic Stress: Two Sides of the Same Coin? | Q58213881 | ||
| Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review | Q58549216 | ||
| IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines | Q58559067 | ||
| Effect of tryptase on mouse brain microvascular endothelial cells via protease-activated receptor 2 | Q58782042 | ||
| An Integrative Approach to Neuroinflammation in Psychiatric disorders and Neuropathic Pain | Q58786635 | ||
| Benchmarking in vitro tissue-engineered blood-brain barrier models | Q59793802 | ||
| Innate Immunity Cells and the Neurovascular Unit | Q60920839 | ||
| Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease | Q64786918 | ||
| Neuroinflammation in mouse models of Alzheimer's disease. | Q64933464 | ||
| Regulation of corticotropin-releasing hormone receptor-2 expression in human cord blood-derived cultured mast cells | Q81571736 | ||
| Mast cells and inflammation | Q83029950 | ||
| Role of Blood-Brain Barrier in Alzheimer's Disease | Q88755604 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic stress | Q3305232 |
| mast cell | Q191989 | ||
| blood–brain barrier | Q221694 | ||
| Alzheimer's disease | Q11081 | ||
| P304 | page(s) | 54 | |
| P577 | publication date | 2019-02-19 | |
| P1433 | published in | Frontiers in Cellular Neuroscience | Q2131509 |
| P1476 | title | Mast Cells in Stress, Pain, Blood-Brain Barrier, Neuroinflammation and Alzheimer's Disease | |
| P478 | volume | 13 |
| Q99588517 | Acute Traumatic Brain Injury-Induced Neuroinflammatory Response and Neurovascular Disorders in the Brain |
| Q98293238 | Current Trends in Biomarkers for Traumatic Brain Injury |
| Q98293236 | Glia Maturation Factor in the Pathogenesis of Alzheimer's disease |
| Q92649296 | Mast Cells in Gut and Brain and Their Potential Role as an Emerging Therapeutic Target for Neural Diseases |
| Q90405221 | Psychological Stress-Induced Immune Response and Risk of Alzheimer's Disease in Veterans from Operation Enduring Freedom and Operation Iraqi Freedom |
| Q94472283 | Stress, Inflammation, and Autoimmunity: The 3 Modern Erinyes |
| Q64902515 | The Role of Mast Cells in Stroke. |
Search more.